These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1344923)

  • 21. Amiodarone-related pneumonitis.
    Chang SN; Hwang JJ; Hsu KL; Tsai CT; Lai LP; Lin JL; Tseng CD; Chiang FT
    J Formos Med Assoc; 2007 May; 106(5):411-7. PubMed ID: 17561478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pulmonary adverse effect after amiodarone treatment--case report].
    Ziora D; Kamiński J; Kozielski J; Oklek K
    Pneumonol Alergol Pol; 1999; 67(5-6):256-62. PubMed ID: 10570648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Peripheral neuropathy possibly caused by amiodarone therapy].
    Oliveira LF; Oliveira Júnior W; de Carvalho FB
    Arq Bras Cardiol; 1991 Jul; 57(1):37-9. PubMed ID: 1668551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myoclonic Jerks and Ataxia: A Case of Rare Neurological Side Effects of Amiodarone.
    Milan-Ortiz V; Damughatla AR; Kamatham S; Jawad ZN; Shakoor S
    Cureus; 2022 Aug; 14(8):e28412. PubMed ID: 36171835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causality assessment of liver injury after chronic oral amiodarone intake.
    Llanos L; Moreu R; Peiró AM; Pascual S; Francés R; Such J; Horga JF; Pérez-Mateo M; Zapater P
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):291-300. PubMed ID: 19165760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amiodarone-induced keratopathy].
    Reĭngardiene DI; Azaravichiene AP; Vashkeliene II
    Kardiologiia; 2003; 43(5):56-9. PubMed ID: 12891242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
    Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary toxicity due to amiodarone].
    Politi A; Galli M; Ferrari G
    Cardiologia; 1993 Feb; 38(2):129-32. PubMed ID: 8324769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung disease caused by amiodarone, a new antiarrythmic agent.
    Gefter WB; Epstein DM; Pietra GG; Miller WT
    Radiology; 1983 May; 147(2):339-44. PubMed ID: 6836114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and secondary effects of chronic treatment with amiodarone].
    Fajuri A; Rodríguez JA; González R; Jalil J; García E; Molgo M; Soza M; Valenzuela P
    Rev Med Chil; 1993 May; 121(5):516-22. PubMed ID: 8272632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peripheral neuropathy induced by amiodarone].
    Domínguez R; Molina HA; Lia Taratuto A; Leiguarda R
    Medicina (B Aires); 1984; 44(4):347-55. PubMed ID: 6100498
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse effects of amiodarone: even after the end of treatment.
    Prescrire Int; 2006 Apr; 15(82):62. PubMed ID: 16604741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.
    Bhagat R; Sporn TA; Long GD; Folz RJ
    Bone Marrow Transplant; 2001 May; 27(10):1109-11. PubMed ID: 11438830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects of oral amiodarone therapy.
    Sinha PR; Dube S; Sujata ; Gupta PR; Avasthey P; Somani PN
    J Assoc Physicians India; 1992 Apr; 40(4):244-6. PubMed ID: 1452532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adverse effects during chronic treatment with low-dose amiodarone].
    Costa C; Visalli N; Natoli A
    Clin Ter; 1985 Jul; 114(1):27-35. PubMed ID: 2994941
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurotoxicity in rats following subchronic amiodarone treatment.
    Rao KS; Fernando JC; Ho IK; Mehendale HM
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):217-24. PubMed ID: 3715200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP; Chang MH; Chang TC; Chou P; Fu CY; Tien LY; Chen CY; Ma TC
    Chin Med J (Engl); 2006 Dec; 119(24):2030-5. PubMed ID: 17199952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal management of amiodarone therapy: efficacy and side effects.
    Hilleman D; Miller MA; Parker R; Doering P; Pieper JA
    Pharmacotherapy; 1998; 18(6 Pt 2):138S-145S. PubMed ID: 9855346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amiodarone and its infusion velocity in recent-onset atrial fibrillation].
    Ramus GV; Veglio F; Bonino ML; Tonda L
    G Ital Cardiol; 1991 Oct; 21(10):1083-91. PubMed ID: 1804746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?
    Pierret C; Tourtier JP; Pons Y; Merat S; Duverger V; Perrier E
    J Laryngol Otol; 2012 Jul; 126(7):701-5. PubMed ID: 22613770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.